These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 6238594)
21. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Jetté L; Léger R; Thibaudeau K; Benquet C; Robitaille M; Pellerin I; Paradis V; van Wyk P; Pham K; Bridon DP Endocrinology; 2005 Jul; 146(7):3052-8. PubMed ID: 15817669 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of growth hormone-releasing factor suppresses both sleep and growth hormone secretion in the rat. Obál F; Payne L; Kapás L; Opp M; Krueger JM Brain Res; 1991 Aug; 557(1-2):149-53. PubMed ID: 1747749 [TBL] [Abstract][Full Text] [Related]
23. Growth hormone-releasing factor-induced growth hormone secretion from perifused rat anterior pituitary cells: lack of influence of glucose concentration, and normal responses in pituitary cells from diabetic animals. Caldwell G; Hart G; Kohner EM; Burrin JM J Endocrinol; 1989 Sep; 122(3):657-60. PubMed ID: 2509615 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of pulsatile growth hormone (GH) secretion and somatic growth in immature rats with a synthetic GH-releasing factor antagonist. Lumpkin MD; Mulroney SE; Haramati A Endocrinology; 1989 Mar; 124(3):1154-9. PubMed ID: 2492921 [TBL] [Abstract][Full Text] [Related]
25. Delayed release formulation of the somatostatin analog RC-160 inhibits the growth hormone (GH) response to GH-releasing factor-(1-29)NH2 and decreases elevated prolactin levels in rats. Bokser L; Schally AV Endocrinology; 1988 Oct; 123(4):1735-9. PubMed ID: 2901338 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of human pancreatic growth hormone-releasing factor and two omission analogs by segment-coupling method in aqueous solution. Blake J; Westphal M; Li CH Int J Pept Protein Res; 1984 Nov; 24(5):498-504. PubMed ID: 6440869 [TBL] [Abstract][Full Text] [Related]
27. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Waelbroeck M; Robberecht P; Coy DH; Camus JC; De Neef P; Christophe J Endocrinology; 1985 Jun; 116(6):2643-9. PubMed ID: 2859987 [TBL] [Abstract][Full Text] [Related]
28. Effects of age on GH responses to growth hormone-releasing factor in rats. Niimi M; Takahara J; Kawanishi K; Irino S Endocrinol Jpn; 1985 Aug; 32(4):559-62. PubMed ID: 3936703 [TBL] [Abstract][Full Text] [Related]
29. Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin. Lanzi R; Tannenbaum GS Endocrinology; 1992 Apr; 130(4):1822-8. PubMed ID: 1347739 [TBL] [Abstract][Full Text] [Related]
30. In vivo studies with growth hormone (GH)-releasing factor and clonidine in rat pups: ontogenetic development of their effect on GH release and synthesis. Cella SG; Locatelli V; De Gennaro V; Pellini C; Pintor C; Müller EE Endocrinology; 1986 Sep; 119(3):1164-70. PubMed ID: 3089765 [TBL] [Abstract][Full Text] [Related]
31. The use of pigs as an animal model to evaluate the efficacy, potency and specificity of two growth hormone releasing factor analogues. Dubreuil P; Brazeau P; Moreau S; Farmer C; Coy D; Abribat T Growth Horm IGF Res; 2001 Jun; 11(3):173-86. PubMed ID: 11735232 [TBL] [Abstract][Full Text] [Related]
32. Growth hormone-releasing factor (GRF) suppresses the in vitro proliferation of mammotrophs from the adult rat. Shinkai T; Ooka H; Noumura T Neurosci Lett; 1991 Feb; 123(1):13-6. PubMed ID: 2062449 [TBL] [Abstract][Full Text] [Related]
36. Effects of neonatal administration of monosodium glutamate on plasma growth hormone (GH) response to GH-releasing factor in adult male and female rats. Wakabayashi I; Hatano H; Minami S; Tonegawa Y; Akira S; Sugihara H; Ling NC Brain Res; 1986 May; 372(2):361-5. PubMed ID: 3085872 [TBL] [Abstract][Full Text] [Related]
37. Association of 45Ca2+ mobilization with stimulation of growth hormone (GH) release by GH-releasing factor in dispersed normal male rat pituitary cells. Login IS; Judd AM; MacLeod RM Endocrinology; 1986 Jan; 118(1):239-43. PubMed ID: 2866951 [TBL] [Abstract][Full Text] [Related]
38. [Diagnostic use of the GRF test in the study of GH secretion]. Ramos M; Fernández A; Ferrández A; Mayayo E; Guallar A An Esp Pediatr; 1987 Oct; 27(4):269-73. PubMed ID: 2892455 [TBL] [Abstract][Full Text] [Related]
39. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor. Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164 [TBL] [Abstract][Full Text] [Related]
40. Effect of hypothalamic ventromedial lesions on plasma growth hormone response to growth hormone-releasing factor in rats. Wakabayashi I; Inoue S; Satoh S; Yamada J; Tonegawa Y; Shibasaki T; Ling N Brain Res; 1985 Oct; 346(1):70-4. PubMed ID: 2864981 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]